Aptargroup Inc
Research Aptargroup Inc (ATR) on Bullrun: valuation model: 6.2% undervalued, market cap USD 8.57B, P/E 24.3, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerATR
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal6.2% undervalued
- Market capUSD 8.57B
- P/E24.3
- Dividend yield1.5%
- Financial periodQ1 2026
- RevenueUSD 982.87M
- Net incomeUSD 72.67M
- Free cash flowUSD 52.71M
- Gross margin35.8%
Valuation Snapshot
Bullrun's latest valuation model marks Aptargroup Inc as 6.2% undervalued; latest market cap is USD 8.57B; P/E is 24.3; dividend yield is 1.5%.
Peer valuation comparison
Latest P/E is 24.34x versus a Healthcare sector median of 24.46x.
Latest dividend yield is 1.45% versus a Healthcare sector median of 2.11% (31.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 3.78B | USD 392.79M | USD 299.58M | 37.2% | 5.89 | USD 402.42M | USD 183.95M | USD 2.67B |
| FY2024 | USD 3.58B | USD 374.54M | USD 366.93M | 37.8% | 5.53 | USD 223.84M | USD 176.04M | USD 2.47B |
| FY2023 | USD 3.49B | USD 284.49M | USD 262.90M | 36.2% | 4.25 | USD 223.64M | USD 81.79M | USD 2.31B |
| FY2022 | USD 3.32B | USD 239.29M | USD 168.19M | n/a | 3.59 | USD 141.73M | USD 3.81M | USD 2.05B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 8.57B | 24.3 | 1.4% | 1.92 |
| 2025 | 2025-12-31 | USD 7.83B | 20.7 | 1.5% | 1.83 |
| 2024 | 2024-12-31 | USD 10.45B | 28.4 | 1.1% | 1.72 |
| 2023 | 2023-12-29 | USD 8.13B | 29.4 | 1.3% | 1.58 |
| 2022 | 2022-12-30 | USD 7.18B | 31.0 | 1.4% | 1.52 |
| 2021 | 2021-12-31 | USD 8.02B | 34.0 | 1.2% | 1.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.92 USD, yield 1.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.83 USD |
| FY2024 | 1.72 USD |
| FY2023 | 1.58 USD |
| FY2022 | 1.52 USD |
About Aptargroup Inc
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Aptargroup Inc overvalued or undervalued?
Bullrun's valuation model currently marks Aptargroup Inc as 6.2% undervalued.
What is Aptargroup Inc's market cap?
Aptargroup Inc's market capitalization is USD 8.57B.
What is Aptargroup Inc's P/E ratio?
Aptargroup Inc's price-to-earnings (P/E) ratio is 24.3.
Does Aptargroup Inc pay a dividend?
Aptargroup Inc has a dividend yield of 1.5%.
What does Aptargroup Inc do?
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures.